Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

In Depth Breadth Analyses of Human Blockade Responses to Norovirus and Response to Vaccination.

Haynes J, Perry V, Benson E, Meeks A, Watts G, Watkins H, Braun R.

Viruses. 2019 Apr 26;11(5). pii: E392. doi: 10.3390/v11050392.

2.

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.

Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, Richardson C, Green KY.

Vaccine. 2012 May 21;30(24):3580-6. doi: 10.1016/j.vaccine.2012.03.050. Epub 2012 Mar 31.

3.

Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques.

Fuller DH, Rajakumar P, Che JW, Narendran A, Nyaundi J, Michael H, Yager EJ, Stagnar C, Wahlberg B, Taber R, Haynes JR, Cook FC, Ertl P, Tite J, Amedee AM, Murphey-Corb M.

PLoS One. 2012;7(3):e33715. doi: 10.1371/journal.pone.0033715. Epub 2012 Mar 19.

4.

H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizers.

Kissmann J, Joshi SB, Haynes JR, Dokken L, Richardson C, Middaugh CR.

J Pharm Sci. 2011 Feb;100(2):634-45. doi: 10.1002/jps.22304.

PMID:
20669328
5.

Influenza virus-like particle vaccines.

Haynes JR.

Expert Rev Vaccines. 2009 Apr;8(4):435-45. doi: 10.1586/erv.09.8. Review.

PMID:
19348559
6.

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.

Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C.

Vaccine. 2009 Jan 22;27(4):530-41. doi: 10.1016/j.vaccine.2008.11.011. Epub 2008 Nov 19.

PMID:
19026705
7.

Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin.

Haynes JR, Arrington J, Dong L, Braun RP, Payne LG.

Vaccine. 2006 Jun 5;24(23):5016-26. Epub 2006 Mar 31.

PMID:
16621198
8.

DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued.

Fuller DH, Rajakumar PA, Wu MS, McMahon CW, Shipley T, Fuller JT, Bazmi A, Trichel AM, Allen TM, Mothe B, Haynes JR, Watkins DI, Murphey-Corb M.

Virology. 2006 Apr 25;348(1):200-15. Epub 2006 Jan 24.

9.

Epidermal DNA vaccine for influenza is immunogenic in humans.

Drape RJ, Macklin MD, Barr LJ, Jones S, Haynes JR, Dean HJ.

Vaccine. 2006 May 22;24(21):4475-81. Epub 2005 Aug 19.

PMID:
16150518
10.

The role of particle-mediated DNA vaccines in biodefense preparedness.

Dean HJ, Haynes J, Schmaljohn C.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1315-42. Epub 2005 Apr 12. Review.

PMID:
15935876
11.

Particle-mediated DNA vaccine delivery to the skin.

Haynes JR.

Expert Opin Biol Ther. 2004 Jun;4(6):889-900. Review.

PMID:
15174971
12.

Needle-free epidermal powder immunization.

Chen D, Maa YF, Haynes JR.

Expert Rev Vaccines. 2002 Oct;1(3):265-76. Review.

PMID:
12901567
13.

Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma.

Payne LG, Fuller DH, Haynes JR.

Curr Opin Mol Ther. 2002 Oct;4(5):459-66. Review.

PMID:
12435047
14.

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

Arrington J, Braun RP, Dong L, Fuller DH, Macklin MD, Umlauf SW, Wagner SJ, Wu MS, Payne LG, Haynes JR.

J Virol. 2002 May;76(9):4536-46.

15.

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.

Fuller DH, Rajakumar PA, Wilson LA, Trichel AM, Fuller JT, Shipley T, Wu MS, Weis K, Rinaldo CR, Haynes JR, Murphey-Corb M.

J Virol. 2002 Apr;76(7):3309-17.

Supplemental Content

Loading ...
Support Center